MedTrace Logo

Alzheimer's Disease Core Center

NCT01421420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2015-06-12

No results posted yet for this study

Summary

The main objective of this research project is to provide a comprehensive clinical database of patients with Alzheimer's disease (AD) and other forms of dementia, individuals with mild cognitive impairment (MCI), and age-matched normal controls. The study will also attempt to identify cognitively normal individuals at genetically defined risk for Alzheimer's disease through genetic screening.

All participants are seen annually. Autopsies to establish diagnoses in patients with dementia, patients with mild MCI, and cognitively normal elderly control subjects will also be conducted.

Conditions

Sponsors & Collaborators

  • Banner Health

    collaborator OTHER

  • Barrow Neurological Foundation

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Arizona

    lead OTHER

Principal Investigators

  • Steven Z Rapcsak, M.D. · University of Arizona

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2024-12-31
Completion
2025-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01421420 on ClinicalTrials.gov